Cortney Caudill
Equibles does not estimate personal net worth.
Get an email with a short summary when Halozyme Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get HALO alertsAbout Cortney Caudill
Cortney Caudill is recorded as COO at Halozyme Therapeutics, Inc. (HALO). The newest filing on record that lists Cortney Caudill as COO at Halozyme Therapeutics, Inc. (HALO) is dated March 23, 2026. Halozyme Therapeutics, Inc. reported in an 8-K filed October 6, 2025 that Cortney Caudill was appointed Senior Vice President, Chief Operating Officer, effective October 1, 2025. The proxy statement of Halozyme Therapeutics, Inc. reports total compensation of $3,202,906 for Cortney Caudill in fiscal 2025, including a base salary of $561,000. Halozyme Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Halozyme Therapeutics, Inc. includes Helen Torley (CEO and Board Member), Darren Snellgrove (CFO), Elaine D. Sun (CFO) and 7 others.
“On October 1, 2025, Cortney Caudill was appointed as Senior Vice President, Chief Operating Officer of Halozyme Therapeutics, Inc. (the "Company"), effective immediately.”
Affiliation history
-
Current
Start not stated–present
Last confirmed March 23, 2026
Company network
Leadership on record at Halozyme Therapeutics, Inc.
- Helen Torley CEO, Board Member
- Darren Snellgrove CFO
- Elaine D. Sun CFO
- Nicole LaBrosse CFO
- Mark Snyder General Counsel
- Barbara Duncan Board Member
- Bernadette Connaughton Board Member
- Connie L. Matsui Board Member
- Dannielle Appelhans Board Member
- James Daly Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Halozyme Therapeutics, Inc. (HALO) | Senior Vice President, Chief Operating Officer | $561,000 | $3,202,906 |